FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Redman Michael Thomas 		2. Issuer Name and Ticker or Trading Symbol

Advanced Environmental Petroleum Producers Inc. [ AEPP ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President
(Last)          (First)          (Middle)

16402 EMILIA COURT 		3. Date of Earliest Transaction (MM/DD/YYYY)

8/3/2017
(Street)

SPRING, TX 77379
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   8/3/2017     A    4400000   A   (1) 2828000   (3) D    
Series A Preferred Stock   8/3/2017     A    14000   (1) A   (1) 28000   (3) D    
Common Stock   8/3/2017     D    61465130   (2) A   (2) 2828000   (3) I   (2) (3) see footnote   (2)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Preferred Stock   $0.075   (1) (4) 8/3/2017     A      14000   (1) (4)      8/3/2017   1/1/2050   (4) Common Stock   14000     (1) 28000   (3) D    
Warrant to acquire Series A Preferred Stock   $0.0825   8/3/2017     A      14000   (1)      8/3/2017   1/16/2020   Series A Preferred Stock   14000     (1) 28000   D    
Option to acquire Common Stock   $0.005   8/3/2017     A      2000000   (1)      8/3/2017   4/25/2021   Common Stock   2000000     (1) 4800000   (1) D    
Option to acquire Common Stock   $0.015   8/3/2017     A      2000000   (1)      8/3/2017   11/28/2021   Common Stock   2000000     (1) 4800000   D    
Option to acquire Common Stock   $0.005   8/3/2017     A      800000       8/3/2017   11/28/2021   Common Stock   800000     (1) 4800000   D    

Explanation of Responses:
(1)  On August 3, 2017, a wholly-owned subsidiary of AEPP, AEPP Merger Sub, Inc., merged with and into Oncolix, Inc. Oncolix was the survivor of the merger (Merger) and Oncolix became a wholly-owned subsidiary of AEPP. In connection with the Merger, the Oncolix securities owned were converted into the right to receive securities of AEPP.
(2)  As reflected on his Form 3 filed on April 11, 2017, Mr. Redman may be deemed a beneficial owner of such 61,465,130 shares owned by Oncolix, Inc., as a result of Mr. Redman being an executive officer of Oncolix, Inc., however, Mr. Redman disclaimed any such beneficial ownership in the 61,465,130 shares owned by Oncolix, Inc. The 61,465,130 shares of common stock owned by Oncolix, Inc. were disposed to, and cancelled by, AEPP in connection with the Merger. While Mr. Reman disclaimed any such beneficial ownership, had he owned any such beneficial interest, Mr. Redman disposed of such beneficial ownership to AEPP in connection with such cancellation as provided for in the Merger.
(3)  Includes (i) 14,000 shares of AEPP common stock issuable upon conversion of AEPP Series A Preferred stock; (ii) 14,000 shares of AEPP Series A Preferred Stock issuable upon exercise of warrants to acquire AEPP Series A Preferred Stock; (iii) 14,000 shares of shares of AEPP common stock issuable upon the conversion of AEPP Series A Preferred Stock that may be acquired pursuant to (ii) herein; and (iv) 2,800,000 shares of AEPP Common Stock that may be acquired pursuant to options.
(4)  Each share of Series A Preferred Stock is convertible into one share of Common Stock, subject to adjustment. There is no expiration date for conversion.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Redman Michael Thomas
16402 EMILIA COURT
SPRING, TX 77379 		X
President

Signatures
Michael T. Redman 9/14/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.